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Edited by Richard MaraisAbstract Sorting nexin 9 (SNX9, also referred to as SH3PX1)
is a binding partner for the non-receptor and Cdc42-associated
kinase (ACK) in Drosophila and mammals. ACK1 is known to
bind clathrin and inﬂuence EGF receptor endocytosis. SNX9
comprises an N-terminal Src homology domain 3 (SH3), a cen-
tral PHOX homology (PX) domain, and a carboxyl-terminal
coiled-coil region. In order to investigate SNX9 further we have
made use of a novel in vivo biotinylation system to label various
GST-SH3 domains and perform blot overlays, thereby identify-
ing synaptojanin-1 as a partner for SNX9. Biotinylated SH3
domains were also used for speciﬁc identiﬁcation of target
proline-rich sequences in synaptojanin and ACK1 on synthetic
peptides arrays. Direct assessment of SH3 binding eﬃciencies
at diﬀerent positions within the extensive proline-rich regions
of these proteins were thus determined. While SNX9 targets a
number of sequences within the proline-rich regions of synaptoj-
anin, a single site was identiﬁed in human ACK1. By testing the
association of various truncations of ACK1 with SNX9 we con-
ﬁrmed the dominant SNX9 binding domain in human ACK1
(residues 920–955). In the presence of SNX9 we ﬁnd that syna-
ptojanin is able to colocalize with distinct ACK1 containing ves-
icles, indicating that this tyrosine kinase is linked to many
components involved in vesicle dynamics including clathrin,
AP2 and synaptojanin-1.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Mammalian ACK1 is a kinase eﬀector for Cdc42 that also
interacts with clathrin and can inﬂuence receptor endocytosis
[1,2]. SNX9 (sorting nexin 9, also referred to as SH3PX1)
was reported to be a binding partner for the non-receptor ki-
nase, activated Cdc42-associated kinase (ACK) in Drosophila
[3], and similar interactions were later reported for the mam-
malian counterparts [4]. This interaction occurs between a pro-
line-rich domain of ACK2 and the Src homology 3 domain
(SH3) of SNX9: co-immunoprecipitation studies indicate that
ACK2, clathrin, and SNX9 can form a complex in cells [4].Abbreviations: HEPES, N-[2-hydroxyethyl]piperazine-N 0-[2-ethane-
sulfonicacid]; ACK, activated Cdc42-associated kinase; DTT, dithi-
othrietol; PAK, p21(Cdc42/Rac) activated kinase; SH3, Src homology
domain 3
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doi:10.1016/j.febslet.2005.07.093Other SH3 containing proteins including Grb2 have been iden-
tiﬁed as partners for ACK although the sites of interaction
have not been mapped [5]. In common with a number of pro-
tein kinases ACK is apparently regulated via heatshock pro-
tein (HSP90) chaperones, that are required for the in vivo
kinase activity of ACK2 and its association with Cdc42 [6].
The SH2 domain of the Drosophila Nck (Dock) adaptor co-
puriﬁes with ﬁve proteins from S2 cells including DACK [7].
The largest protein in the complex was identiﬁed as an ortho-
logue of Dscam (Down syndrome cell adhesion molecule),
which plays a role in directing neurons of the ﬂy embryo to
correct positions within the nervous system [8]. The smallest
protein in this complex (p63) was DSH3PX1 (DSNX9), that
is similar to mammalian SNX9 comprising of an NH2-termi-
nal SH3 domain, an internal PHOX homology (PX) domain,
and a carboxyl-terminal coiled-coil region. SNX9 is a member
of a family of proteins known collectively as sorting nexins,
some of which have been shown to be involved in vesicular
traﬃcking [9]. Both Dock SH3 and SH2 domains appear to
mediate association with DSNX9 but the exact determinants
of interaction have not been uncovered.
A number of methods have been developed to assess direct
protein interaction by protein overlays onto proteins arrayed
on membranes. We have previously described the use of a glu-
tathione-S-transferase Ras fusion protein system to generate
probes fused to domains of choice which can be rapidly la-
belled with [c-32P] GTP with similar sensitivity to direct 32P
labelling of proteins [10]. Because of the hazards associated
with radiolabelling techniques and requirement for specialized
disposal of waste, non-radioactive methods are in ascendancy.
Indirect labelling methods include antibodies directed against
the protein probe or the use of chemical labels that can then
be detected via enzymic or chemiluminescent methods.
The modiﬁcation of proteins by covalent attachment of bio-
tin occurs to very few proteins, one in Escherichia coli, three in
budding yeast and four in mammalian cells. Biotin attachment
is a 2-step reaction that results in the formation of an amide
linkage between the carboxyl group of biotin and the e-amino
group of the modiﬁed lysine. The unique E. coli biotin acceptor
is biotin carboxyl carrier protein (BCCP) which is recognized
by the BirA enzyme. Speciﬁc biotinylation of small peptides
(14–23 residues) by BirA in vivo was demonstrated by a
phage-based selection protocol: the resultant consensus se-
quence for biotinylation by BirA has little similarity to the pri-
mary sequence of BCCP [11]. Such peptides have formed the
basis for the development of hybrid vectors expressing aﬃnity
fusion proteins such as maltose binding protein [12].blished by Elsevier B.V. All rights reserved.
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tide of only 10 residues is placed in the pGEX expression vec-
tor also encoding a polycistonic mRNA that includes the BirA
enzyme. This vector allows for the in vivo attachment of biotin
to proteins or domain of choice that can be puriﬁed using one
step aﬃnity chromatography on glutathione sepharose. Subse-
quently these proteins can be used as probes, which we have
previously shown to be much more eﬀective when arrayed as
GST dimers [10] particularly when dealing with SH3 aﬃnities
in the 0.1–10 lM range. Such modiﬁed proteins can also be
immobilized via streptavidin to surfaces such as ELISA plates
or plasmid resonance chips for solid phase assays.
Based on our previous work [13] and the observation that
SNX9 is a partner for ACK, we have investigated interactions
involving the SH3 domain of SNX9, and identiﬁed for the ﬁrst
time synaptojanin-1 as an alternate partner. This SH3 domain
can bind a single site in ACK1, but multiple sites in the pro-
line-rich domain of synaptojanin; one synaptojanin site only
overlaps previously characterized synaptojanin partners
amphiphysin and endophilin. When SNX9 binding to ACK1
was investigated in the context of full-length proteins, SNX9
was found to interact preferentially with inactive ACK1. This
is consistent with a previous proposal [7] that phosphorylation
of SNX9 by ACK (or Src kinases) downregulates SH3 binding
to its target sequences. On this basis we suggest that ACK1
both binds to and regulates interaction of SNX9 with other
proteins involved with endocytosis, including synaptojanin-1.2. Materials and methods
Chemicals and reagents were obtained from Sigma, unless otherwise
stated. Restriction enzymes and restriction digest buﬀers were from
New England Biolabs. T4 DNA ligase and buﬀer were obtained
from GIBCO-BRL. Horseradish-peroxidase-coupled streptavidin was
from Amersham Life sciences.
2.1. Plasmid construction
Nucleic acid manipulations were carried out as described previously
[14]. The pGEX-4T-1 vector (Pharmacia) was modiﬁed to allow both
transcription of the GST fusion proteins containing biotin acceptor
site and the BirA gene under E. coli tac promoter (Ptac), for inducible
and high-level expression in conjunction with an internal lac Iq gene.
The E. coli biotin holoenzyme synthetase (BirA) was ampliﬁed from
E. coli geneomic DNA using the following: forward primer 5 0
GCTGTCGACC TCGAGTAA GA AGGAGACAAT TTCAT-
GAAGG; reverse primer 5 0 GATTGCGGCC GCTTA TTTTT
CTGCACTACGC. The ampliﬁed 1 kb BirA fragment was then ligatedFig. 1 A modiﬁed pGEX-4T vector plasmid allowing expression of
biotinylated proteins. (A) The pGEX-4T-BiotinN was generated in
two versions containing either an 18 or 10 amino-acid N-terminal
peptide acceptor sequence is indicated. For the 10 residue construct the
open reading fame continues in frame with the ﬁrst restriction enzyme
site (BamHI, GGATCC) in the polylinker. The position of the various
unique restriction sites in the vector are shown. The NotI site is present
3 0 to the BirA open reading frame, but an additional Kpn1 site (relative
to parental vector) has been added to compensate. (B) The pGEX-4T-
BiotinC vector contains the same internal ribosome binding site and
BirA sequence, but contains a polylinker sequence upstream of the
biotin acceptor sequence as shown. (C) MALDI-TOF spectra of
peptides isolated from the pGEX-4T-BiotinN vectors encoding 18mer
or 10mer acceptor peptides as shown in (A). The presence of an
additional internal cleavage site is indicated by presence of a smaller
peptide (calculated as cleaved at position shown).
cinto the SalI/NotI sites. A 3-frame translational termination codon
containing a KpnI (see Fig. 1) was placed at the end of the polylinker
region in the existing SmaI/XhoI sites.
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recombinant protein substrates for enzymatic biotinylation in a cou-
pled translational arrangement with BirA. Fig. 1. shows the position
of the internal ribosome entry site for the expression of the BirA
ORF. pGEX-4T-Biotin includes a 3-frame translational termination
as for the parental vector. The modiﬁed regions of the plasmids were
completely sequenced on both strands.
Generation of pGEX-4T-BiotinN, was performed using oligonucle-
otides containing the biotin acceptor sequence (Fig. 1) and compatible
overhangs for cloning into BamHI/EcoRI sites of the plasmid pGex
4T-1 (Parmacia). For the cloning of the C-terminal biotin vector, the
BirA fragment which contained the 3-frame translational termination
sequence with a KpnI site was excised from the N-terminal biotin vec-
tor by SalI/NotI digest. It was then cloned into the corresponding sites
in pGex 4T-1 vector. An annealed oligonucleotide pair (containing the
biotin acceptor sequence) was cloned into KpnI/XhoI sites which
placed the biotin tag after the polylinker sequence. Forward primer
5 0 CCTCGAGGGA GGCCTGAAAC CAATTTTCGAA GCACA-
GAAAA TGGAATGGCG ATCTAACAAG TGAT:; reverse primer
5 0 TCGAATCACT TGTTAGATCG CCATTCCATT CGAAAATT
GG TTTCAGGCCT CCCTCGAGG GTAC. The resultant plasmid
was digested with KpnI enzyme and ﬂushed with T4 polymerase to gen-
erate the biotin acceptor sequence (Fig. 1).
The C-terminal biotin vector was derived by cloning the BirA frag-
ment SalI/NotI digest in pGex 4T-1 vector. Annealed oligonucleotides
containing the biotin acceptor sequence as shown in Fig. 1B was
cloned into KpnI/XhoI sites which placed a biotin tag after the poly-
linker sequence. Forward primer CCTCGAGGGA GGCCTGAAAC
CAATTTTCGA AGCACAGAAA ATGGAATGGC GATCTA-
ACAA GTGAT Reverse primer: 5 0-TCGAATCACT TGTTA-
GATCG CCATTCCATT TTCTGTGCTT CGAAAATTGGTTTC
AGGCCT CCCTCGAGGG TAC-3 0 The resultant construct was di-
gested with KpnI enzyme and ﬂushed with T4 polymerase to place
the biotin acceptor sequence in frame as indicated (see Fig. 1).
cDNA encoding full-length or the SH3 domain of human SH3-PX1
(residues 1–62) was ampliﬁed from corresponding cDNA by PCR and
cloned into pGEX-4T-BiotinN or pGEX-Ras vector (1). The cDNA
encoding a PAK1-250 was ampliﬁed as a BamHI/XhoI fragment and
cloned into pGEX-4T1 or pGEX-4T-BiotinN. Grb2 and Nck
constructs are previously described [13]. Human synaptojanin-1 was
similarly cloned into pXJ-GST vector. Various truncation constructs
of human ACK1 were derived by polymerase chain reaction ampliﬁca-
tion of ACK1 using synthetic oligonucleotide primers, and conﬁrmed
by sequencing. Full-length a PAK was cloned in pGEX-4T-BiotinC
as a BamHI/XhoI fragment using E. coli JM109 grown at 30 C. Other
plasmid DNA manipulation was carried out in the XL-1blue strain
(Stratagene): plasmid DNAwas prepared using QIAprep spin miniprep
kit. Puriﬁed DNA was quantiﬁed by absorption at 260 nm.
2.2. Protein expression and puriﬁcation
Expression and puriﬁcation of glutathione-S-transferase (GST) fu-
sion proteins was carried out using BL21-DE3 strain under standard
conditions. Columns (0.5 ml) were washed with buﬀer A and eluted
in 2 volumes of the same buﬀer containing 10 mM reduced glutathione
and 5% glycerol. Protein concentrations were determined using the
Biorad dye reagent (using OD595 of 0.3/ml = 10 lg protein). The pro-
teins were divided into aliquots, snap frozen in liquid nitrogen and
stored at 80 C.
2.3. Blot overlays and biotin detection
Proteins were fractionated by SDS–gel electrophoresis, and trans-
ferred to PVDF membranes. Both PepSpot cellulose ﬁlters and PVDF
membranes were blocked with 5% BSA/PBS. To detect biotinylated
proteins the blots were probed with HRP–streptavidin (Amersham) di-
luted 1:5000 in PBS/0.1% Triton X-100 at room temperature. For blot
overlays, ﬁlters were incubated with 10 lg/ml of relevant biotinylated
or 32P-labelled GST fusion protein in 1% BSA/PBS for 2 h at room
temperature. Washes with PBS/0.1% Triton X-100 (3 · 5 min) were
performed at room temperature. Bands were visualized with ECL re-
agent (Amersham Pharmacia biotech) and recorded on X-ray ﬁlm
(Hyperﬁlm) by contact exposure for 2–30 s. PVDF membranes or
polyacrylamide gels (1.5 mm) were stained with Coommassie brilliant
blue (in 40% methanol/10% acetic acid) for 1 min or 1 h, respectively.
Destaining was carried out with 40% methanol/10% acetic acid for
2 min or 2 h.2.4. Peptide synthesis
Peptide synthesis was carried out using cellulose-bound PepSpots
peptide synthesis (Jerini AG) with N-terminal acetylation. For syna-
ptojanin 1058–1303 residues were arrayed as 12mers displaced by 3
residues between adjacent positions (total 79 peptides). For ACK1
621–940 the peptide array consisted of 13mer peptides displaced by 4
residues (total 82 peptides). The N-terminal region (Fig. 3B, boxed)
consists of a proline-rich exon found in some alternate spliced versions
of ACK1 and reported in ACK2 (see text for details).
2.5. MALDI analysis
Dialysis was carried out using 10000 Mr cut-oﬀ dialysis cassettes
(Slide-A-Lyzer, Pierce). GST fusion proteins (0.5 ml) were injected into
each cassette and dialysed overnight against 10 mM N-[2-hydroxy-
ethyl]piperazine-N 0-[2-ethanesulfonicacid] (HEPES), pH 7.3, 1 mM
dithiothrietol (DTT). Bovine thrombin (Sigma) was used at 10 U/ml
to cleave the acceptor peptide from GST. The reaction mixture was
incubated for 2 h at room temperature. Matrix-assisted laser desorp-
tion ionization time of ﬂight (MALDI-TOF) spectrometry was carried
out at 5–50 pmol/ll (in 1:1 v/v ACN/ 0.1%TFA) on a Voyager XL
spectrometer.
3. Results
3.1. Generation of biotinylated GST-fusion proteins
Using data gleaned previously from phage display analysis
of BirA acceptor peptides [11] we constructed an expression
vector in which glutathione-S-transferase was expressed in tan-
dem with a biotin acceptor peptide of 18 residues (Fig. 1A
underlined), allowing cloning of downstream proteins. The
expression of proteins or domains from this vector was devel-
oped to allow their use as overlay probes, but can also allow
for immobilization via streptavidin in solid phase assays (cf
ELISA), or for surface plasmon resonance (SPR) experiments.
Since the level of BirA (the enzyme which attaches biotin to the
acceptor sequence) in E. coli is rather low we included an inter-
nal ribosome entry site (IRES) upstream of the open reading
frame encoding BirA. A second vector was derived whereby
proteins could be tagged at the C-terminus (Fig. 1B).
To assess the extent of modiﬁcation we isolated GST protein
derived from the pGEX-4T-1 vector modiﬁed with the 18 res-
idue acceptor, and subjected it to thrombin cleavage followed
by mass analysis of the released peptide(s) by MALDI-TOF.
Surprisingly four rather than two peaks were detected
(Fig. 1C) comprising two pairs separated by 126 Da, being
parent and biotinylated peptide products. The mass of the lar-
ger species indicated full-length biotin-modiﬁed peptide se-
quence derived from the N18 sequence and downstream
polylinker (shown below the panel = 3738.6 Da): while the
smaller product suggested cleavage at WR/SN in the biotin
acceptor peptide (arrow). The ratio of parent to biotinylated
peptide for both showed 70–75% of the released peptide con-
tained biotin.
Since there was no indication of a C-terminal fragment de-
rived from peptide cleavage at WR/SN, we concluded that
cleavage occurred prior to puriﬁcation (i.e., not due to promis-
cuous thrombin activity). In order to circumvent such internal
cleavage which can occur at the basic residues (actually within
the biotinylation target sequence) we removed 5 residues C-ter-
minal to the arginine present in the Biotin18 sequence thus
yielding WRGS at the previous cleavage junction (see Biotin-
10). In addition we removed LKP from the N-terminus (this
basic residue might promote protease activity). Although Bio-
tin10 lacks residues N-terminal and C-terminal to the acceptor
lysine that previously implicated in recognition by BirA [15], it
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lower panel) with no evidence of internal cleavage. The mass
of the major peptide (2957.3) corresponds to the expected bio-
tin modiﬁed peptide derived from the vector (factoring in iso-
topic composition).
The eﬃcacy of the system was tested using a variety of con-
structs encoding protein domains (see Supplementary ﬁgure 1).
The higher than expected eﬃciency of streptavidin–agarose
retention of the biotinylated proteins (versus protein modiﬁca-
tion as assessed by MALDI-TOF) arises from the exclusively
dimeric nature of GST fusion proteins.3.2. Identiﬁcation of SH3PX-1 binding partners by overlay
We have previously established that SH3 targets can be iden-
tiﬁed by corresponding GST fusion proteins using proteins ex-
tracted from appropriate tissues in blot overlay format [13].
We used the biotinylated probe to investigate the SH3 domain
of SNX9 or sorting nexin 9 (SNX9), a partner for the Cdc42
target ACK [4]. Fig. 2A shows that in spite of background
bands arising from the presence of endogenous biotinylated
proteins (starred) we are able to detect two SNX9 targets (ar-
rows) in brain but not testis lysate. In order to enrich these for
sequence analysis we performed a single step aﬃnity puriﬁca-
tion from brain lysate [13] which yielded SNX9 binding pro-
teins of 97 and 145 kDa (Fig. 2B, arrows). These two species
were seen by Coommassie blue staining although an additional
contaminant at 97 kDa is also seen. Lower abundance targets
such as ACK1 may be present but probably require additional
enrichment steps of the starting material. MALDI analysis of
tryptic peptides derived from gel-puriﬁed bands identiﬁed p145
as synaptojanin-1, while the 97 kDa protein was (as expected)
dynamin. The latter is extremely abundant in brain prepara-
tions and routinely recovered with SH3 domains (data not
shown, [13]).
Fig. 2. Detection and puriﬁcation of SNX9 binding proteins. (A)
Protein lysates (50 lg) derived from rat brain (B) or testis (T) were
prepared as described [13] , run on 9% acrylamide gels, and transferred
to PVDF for overlay with biotin labelled GST (left) or GST-SH3 as
indicated. Two prominent bands seen with GST alone (stars) corre-
spond to endogenous biotinylated proteins detected by strepavidin–
HRP. Two prominent additional bands were detected in the brain
puriﬁed fraction (arrows), therefore brain extracts were used for
further study. (B) Brain lysate was passed through immobilized GST
or GST-SNX9(1–62) sepharose as previously described [13]. In brief,
lysates derived from rat tissues were prepared in 40 mM HEPES, pH
7.3, 0.1 M NaCl, 1% Triton X-100, 1 mM sodium vanadate, 25 mM
sodium ﬂuoride, 5% glycerol, 5 mM DTT, and complete protease
inhibitor cocktail (Boehringer). Aﬃnity puriﬁcation was carried out in
0.2 ml columns containing 5 mg/ml immobilized GST-SH3 were
loaded with 40 mg lysate, washed with 10 column volumes of the
same buﬀer and eluted by heating (80 C, 10 min) in SDS sample
buﬀer. The eluted proteins were separated on 9% polyacrylamide gels
and transferred to PVDF for staining (left panel) or overlaid with
biotin labelled GST-SNX9(1–62).3.3. Peptide scan analysis of SH3 binding sites on synaptojanin-1
and ACK1
Both synaptojanin-1 and ACK1 contain C-terminally lo-
cated proline-rich domains that we considered likely to repre-
sent multiple sites for binding to SNX9 and/or other SH3
containing partners. The use of synthetic peptides to identify
such site(s) greatly simpliﬁes the process of SH3 target identi-
ﬁcation. Fig. 3A and B shows GST-biotin-SH3 overlay using
ﬁlter peptide arrays containing immobilized 12 or 13 mers that
scan across proline-rich regions of the two protein as indicated.
The sequence of the peptides giving the strongest signals with
biotin-labelled SH3 domains are shown in Fig. 3C. We chose
to use the second SH3 domain of Nck (Nck SH3-2) as a con-
trol for synaptojanin-1 since we previously identiﬁed a poten-
tial binding site in silico [13]. Other binding sites in
synaptojanin for endophilin SH3 (E1) and amphiphysin SH3
(A1 and A2) have previously been mapped [16,17]. SNX9
clearly interacts strongly with synaptojanin at multiple binding
sites (S1–3): while binding site S1 overlapped with one of those
for amphiphysin (A1) the other two sites do not overlap with
the known synaptojanin binders. The single Nck SH3-2 bind-
ing site in synaptojanin-1 ﬁts the PxxPxRxxS consensus we
previously derived [13].
SNX9 binds ACK1 strongly at only one (S5) of the 11
PxxP motifs within the ACK1 621-940 sequence. Minor con-
tribution (S4) is seen from an alternate spliced proline-richexon (REPPPRPPQPAFFTQ, boxed in Fig. 3B) just C-ter-
minal to the CRIB motif in bovine ACK2 [18] and present
in 50% of human and rat ACK1 brain mRNAs as deter-
mined by RT-PCR (Chan Wing, unpublished data). The
S5 peptide is not present in the ACK2 and therefore we as-
sume interaction of SNX9 in this situation relies on the S4
peptide. All sequences recognized by SNX9 identiﬁed here
are proline and arginine rich (bold type) but no clear
consensus is noted in terms of placement of the prolines
and arginines, suggesting that these peptides might be
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to as type 1 and II [19]). We used Grb2 which has been re-
ported to interact with ACK1 [5] as control: both N-termi-
nal and C-terminal SH3 domains gave essentially identical
results (data not shown). Grb2 binds to ACK1 strongly at
peptide G1, a binding sequence that does not fulﬁl the type
1 consensus for Grb2 RxxPxxP, however Grb2 can bind in
the type II orientation with equal aﬃnity [20]. Taken to-
gether the results indicate that we can detect signiﬁcant spec-
iﬁcity to SH3 binding even under such in vitro conditions.
SH3 selectivity relies on negative selection (i.e., residues that
are not tolerated at certain positions) as much as positive
selection of amino acids surrounding the PxxP box [13].
3.4. SNX9 binding requires ACK1 residues 920–955
Since the peptide S5 (in the ACK1 array) apparently
represented the major SNX9 binding site, we tested this pre-
diction by looking at the ability HA-ACK1 proteins to co-
immunoprecipitate with Flag-SNX9 (Fig. 4). The kinase
lacking the C-terminal double ubiquitin-associated (UBA)
domains (residues 955–1031) bound well to Flag-SNX9
(Fig. 4, construct 1), as did a construct lacking the N-termi-
nal kinase and SH3 domains (top panel, construct 447–955
also starred). There is a drop in relative eﬃciency of binding
(comparing input to levels in IP) which is likely due to the
loss of a dimerization domain at the extreme N-terminus of
ACK1 (data not shown). It is likely that SNX9 also occurs
as dimers mediated by its coiled-coil region, thus allowing
more stable association of the two dimers. Removal of the
region containing the S5 peptide (i.e., 920–955) yielded a
construct that was essentially unable to bind SNX9. Re-
moval of the EGF receptor binding domain (construct 3 ver-
sus 4) or the major Grb2 binding site (construct 4 versus 5)
has no eﬀect on SNX9 binding.
3.5. SNX9 binding is negatively regulated by ACK1 activity
Over-expressed full-length ACK1 is primarily located in the
insoluble fraction (95% of the full-length kinase), probably
corresponding to clathrin containing aggregates we have de-
scribed previously [1]. In spite of these limitations we were
interested to discover if the activity of mammalian ACK1
inﬂuenced its ability to associate with SNX9. In this experi-
ment we used clathrin as a positive control, as illustrated in
Fig. 5 ACK1 contains a central clathrin binding box [1].
Fig. 5A is typical of the results obtained using Flag-SH3PX
or Flag-clathrin. Consistently kinase inactive ACK1(KD)
bound to SNX9 more eﬃciently than the catalytically activeFig. 3 Detection and puriﬁcation of SH3 target sequences in
synaptojanin-1 and ACK1. (A) Synthetic peptides corresponding to
sequence derived from human synaptojanin-1 (GenBank AAC5192)
residues 1058–1303 were arrayed as 12mers sequentially displaced by 3
residues between adjacent positions (total 79 peptides). The cellulose
ﬁlter was overlaid with biotin-labelled GST-SH3 fusion proteins
(10 lg/ml) as indicated. Binding was detected by streptavidin–HRP, all
X-ray ﬁlm exposures are for identical times. Filters were stripped using
1% SDS, 10 mM DTT in PBS at 50 C, 15 min and checked for
residual signal. (B) The human ACK1 621–940 peptide array consist-
ing of 13mer peptides displaced by 4 residues (total 82 peptides). The
boxed region represents the proline-rich exon adjacent to the Cdc42
binding domain found in some alternate spliced versions of ACK1 and
present in bovine ACK2. Overlays were performed as in (A).
b
Fig. 4. Identiﬁcation of an essential region in ACK1 for SNX9
binding. Constructs of HA-tagged ACK1 that were used for co-
transfection experiments in COS7 cells are shown schematically. The
domains of ACK1 are abbreviated as follows: Dim, dimerization
domain; CRIB, Cdc42/Rac interaction binding domain; CBD, clathrin
binding domain; EGFR, epidermal growth factor receptor binding
domain (conserved with Gene33); ubiquitin associated domain (UBA).
Flag-SNX9 was immunoprecipitated and co-precipitating HA-ACK1
proteins are indicated by asterisks. The heavy (HC) and light chains
(LC) of IgG are indicated. The larger construct 1 lacks the ubiquitin
associated domain (UBA) residues 955–1031. The N-terminal kinase
and SH3 domains are not essential for binding, however ACK1 447–
920 (construct 3) did not bind to SNX9. The input (lower panel)
contains 50 lg of protein per lane, while the immunoprecipitate
corresponds to recovery from 250 lg of COS7 lysate. The recovery of
SNX9 was determined by Coommassie staining of the blot (PVDF)
prior to probing with anti-HA antibodies.
Fig. 5. Kinase activity can aﬀect the binding of ACK1. (A) Vectors
encoding the constructs as indicated were transfected into COS7 cells,
and cell lysates subjected to immuno-precipitation using Flag-M2
sepharose. Either full-length human ACK1 or kinase inactive
ACK1K158R mutant was used in the experiment: both were expressed
at equivalent levels in total lysates. The latter is not detected by anti-
phospho-tyrosine antibodies (Mab 4G-10). SNX9 binds preferentially
to ACK KD while clathrin 1–579 overall interacts more weakly. (B)
Full-length Grb2 but not Nck interacts with kinase inactive
ACK1K158R (KD). Immunoprecipitates (anti-FlagM2 beads) were
tested for the presence of HA-ACK1K158R as indicated.
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SNX9 to the proline-rich region. The exact mechanism under-
lying this process is presently under study: ACK1 does under-
go tyrosine auto-phosphorylation at multiple sites but there is
no phosphorylatable group proximal to the SNX9 binding re-
gion (i.e., within ACK1 920–955). Alternatively ACK1 activity
might aﬀect SNX9 (for example by direct or indirect phos-
phorylation) as for Drosophila ACK can act in vitro on
DSNX9 at Tyr-56, located within the SH3 domain of DSNX9
[7]. However since we were able to co-immunoprecipitate tyro-
sine-phosphorylated SNX9 with active ACK1 it is likely the
mechanism is diﬀerent (data not shown).
Drosophila. Dock immuno-precipitates were found to con-
tain high levels of DAck [3]. This has not been shown for
the mammalian orthologue and indeed peptide array datausing the second SH3 domain of Nck suggested this adaptor
does not bind ACK1 (Fig. 3B). We tested this potential inter-
action by co-immunoprecipitation (Fig. 5B) and found mam-
malian Nck could not bind ACK1 (via any of its three SH3
domains), while as a positive control binding of Grb2 and
ACK1 was readily detected. The Grb2 binding to ACK1 under
these experimental conditions likely occurs through a central
proline-rich sequence identiﬁed as G1 (Fig. 3B) and corre-
sponding to ACK1(737–750).
3.6. Colocalization of synaptojanin and ACK1 requires SNX9
Since SNX9 contains a region of coiled-coil in its C-terminal
implicated in oligomerization, we were interested in the possi-
bility that this protein might be able to bridge ACK1 and syn-
aptojanin-1. Expression of ACK1 in mammalian cells leads to
Fig. 6. Colocalization of ACK1 with synaptojanin via SNX9. (A–D) Hela cells were transiently transfected with constructs encoding HA-ACK1,
Flag-SNX9 and GST-synaptojanin-1 as indicated. The proteins were localized using antibodies directed toward the various tags. SNX9 and
synaptojanin were found associated in the same peripheral structures (arrow, top panels). By contrast ACK and synaptojanin were not colocalized to
the vesicles (C) unless SNX9 was also expressed (D). Note in this panel that the cell lacking ACK1 on the right side shows a uniform distribution of
synaptojanin1 except at the cell periphery.
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in Fig. 6. This allows one to clearly detect the redistribution of
protein partners in co-transfection experiments. SNX9 and
synaptojanin-1 showed a similar distribution in Hela cells
which was particularly evident at the cell periphery (Fig. 6,
top panel A). However synaptojanin-1 only colocalized in a
few regions of the cell with ACK1 structures unless co-trans-
fected with SNX9 (Fig. 6 lower panel D). Here the binding
of synaptojanin to these ACK1–rich structures was very clear.
On this basis we propose that SNX9 oligomers can mediate
simultaneous binding to more than one of their SH3 domain
partners.4. Discussion
This study describes a system for quantative in vivo biotin-
ylation of GST expressed fusion proteins in E. coli. Our 18 res-
idue acceptor sequence performed well in terms of
biotinylation, but underwent signiﬁcant proteolysis in vivo
probably by basic directed bacterial proteases. Shortening
the acceptor sequence to 10 residues appeared to completely
resolve this problem while maintaining the stoichiometry of
modiﬁcation (Fig. 1C).
Mammalian activated Cdc42 associated kinase (ACK1) was
the ﬁrst eﬀector to be described for the Rho family and is a
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Rac1 or RhoA via a PAK-like CRIB motif [21]. The associa-
tion of ACK1 with Cdc42 and adaptors such as Grb2 is likely
to provide localization cues for the kinase (6). That kinase-
dead ACK1 can interact with Grb2 but not with Nck
(Fig. 4B) is consistent with the peptide overlay data
(Fig. 3B): thus Nck binding would requires interaction of the
SH2 domain with phospho-tyrosine residues on ACK1.
The domain structure of ACK kinases consists of an N-ter-
minal tyrosine kinase catalytic domain followed by an SH3 do-
main, a Cdc42 binding domain, clathrin binding domain and a
proline-rich C-terminal region terminating in two UBA boxes
(Fig. 4). Here we have identiﬁed diﬀerent binding sites in the
extensive proline-rich region of ACK1 for both Grb2 and
SNX9. This paves the way for future studies to address the
issue of how these proteins might modulate ACK1 localization
and activity. A connection between Nck and ACK1 was sug-
gested by studies of the Drosophila orthologue of Nck (Dock):
using an epitope-tagged SH2 domain of Dock ﬁve proteins
were identiﬁed (molecular masses of 270, 145, 74, 69, and
63 kDa) in immuno-precipitates [22]. The 145 kDa protein rep-
resented DAck1 and the 63 kDa protein identiﬁed as DSNX9.
Although the SH3 domain of DSNX9 can bind the orthologue
of Wiskott-Aldrich Syndrome protein (WASp), we did not
identify this interaction in our analysis of SNX9 binding pro-
teins (Fig. 2). DSNX9 is a substrate for DAck in vivo and
in vitro [7] and a major site of DSNX9 phosphorylation is
the conserved tyrosine residue (Tyr-56) present in the N-termi-
nal SH3 domain that appears to block SH3 function. However
we were able to detect tyrosine-phosphorylated SNX9 co-pre-
cipitating with ACK1.
Sorting nexins (SNXs) are 400–700 amino-acid hydrophilic
proteins that are characterized by the presence of a phospho-
lipid-binding domain, the PX domain. In addition to the PX
domain, SNXs have various protein–protein interaction motifs
that are thought to determine their sub cellular localization
and their ability to form speciﬁc complexes (as reviewed by
Worby and Dixon [9]). Mammalian SNXs are thought to be
important for the sorting of proteins in the endosomal path-
way. Both over-expressed ACK2 or epidermal growth factor
(EGF) can stimulate the tyrosine phosphorylation of SNX9
[4]. Both clathrin and dynamin-2, two other essential molecules
in the endocytic process, interact with SNX9. CIN85 SH3 do-
mains have recently been shown to pull-down synaptojanin-1
[23]: the authors identiﬁed four proteins in SH3 pull-downs
but could only verify synaptojanin-1 and PAK2 as direct bind-
ers by overlay [23]: all three CIN85 SH3 domains bound syn-
aptojanin-1. Other potential synaptojanin-1 binders are
ArgBP2 and FISH [20]. What would be the signiﬁcance of
the interaction between SNX9 and synaptojanin? Synaptoja-
nin-1 is a polyphospho-inositide phosphatase implicated in
synaptic vesicle recycling and thus membrane traﬃcking. Cul-
tured cortical neurons from synaptojanin-1 knockout mice
show relatively normal endocytosis after a moderate synaptic
stimulus but during prolonged stimulation the regeneration
of fusion-competent synaptic vesicles is severely impaired
[24]. These ﬁndings implicate synaptojanin-1 in progression
and maturation of recycling vesicles: the participation of
SNX9 which contains an inositol lipid binding domain (PX)
would not be unexpected. It is thought endophilin is required
to localize and stabilize synaptojanin-1 at membranes duringsynaptic vesicle recycling [25] however the potential participa-
tion of SNX9 deserves further study. The endophilin binding
site in the synaptojanin C-terminal [17] does not overlap with
sites we identify here for SNX9 (see Fig. 3A). Distinct sites for
another SNX9 partner synaptophysin 1 are also marked in
Fig. 3 (A1 and A2).
ACK1 can be localized to clathrin-coated vesicles [1]. The
association of SNX9 with synaptojanin-1 would suggest the
two cooperate during endocytosis at the synapse by coupling
the sorting nexin to changes in phospholipid composition.
ACK1 in turn negatively regulates the association of SNX9
with targets probably via phosphorylation of Y56 (as shown
for the Drosophila protein). While the speciﬁc role of ACK1
in clathrin-coated vesicle-mediated endocytosis remains to be
established, the observation that ACK1 is associated with ves-
icles relatively depleted in clathrin [1] suggests that an associa-
tion with partially uncoated vesicles, an event occurring prior
to docking or fusion with endosomes.
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